Samrat Pharmachem [SAMRATPH] vs Deepak Nitrite [DEEPAKNTR] Detailed Stock Comparison

Samrat Pharmachem

BSE
Loading...

Deepak Nitrite

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Samrat Pharmachem wins in 9 metrics, Deepak Nitrite wins in 10 metrics, with 0 ties. Deepak Nitrite appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSamrat PharmachemDeepak NitriteBetter
P/E Ratio (TTM)20.0041.67Samrat Pharmachem
Price-to-Book Ratio1.344.69Samrat Pharmachem
Debt-to-Equity Ratio13.8123.36Samrat Pharmachem
PEG Ratio-0.18-0.93Deepak Nitrite
EV/EBITDA13.6126.23Samrat Pharmachem
Profit Margin (TTM)1.72%7.58%Deepak Nitrite
Operating Margin (TTM)-0.06%7.32%Deepak Nitrite
EBITDA Margin (TTM)N/A7.32%N/A
Return on Equity9.91%11.85%Deepak Nitrite
Return on Assets (TTM)5.85%9.03%Deepak Nitrite
Free Cash Flow (TTM)$-105.99M$-5.12BSamrat Pharmachem
Dividend Yield0.29%0.41%Deepak Nitrite
1-Year Return-44.72%-34.84%Deepak Nitrite
Price-to-Sales Ratio (TTM)0.343.16Samrat Pharmachem
Enterprise Value$1.06B$256.48BDeepak Nitrite
EV/Revenue Ratio0.383.20Samrat Pharmachem
Gross Profit Margin (TTM)2.99%21.99%Deepak Nitrite
Revenue per Share (TTM)$908$587Samrat Pharmachem
Earnings per Share (Diluted)$15.59$44.44Deepak Nitrite
Beta (Stock Volatility)-0.400.14Samrat Pharmachem
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Samrat Pharmachem vs Deepak Nitrite Stock Performance Analysis

Loading Price Chart...

Samrat Pharmachem
Deepak Nitrite
Samrat Pharmachem Stock Overview | Deepak Nitrite Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Samrat Pharmachem-1.52%3.37%-4.23%-18.68%-2.82%-21.57%
Deepak Nitrite-0.43%0.56%5.64%-6.88%1.10%-26.19%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Samrat Pharmachem-44.72%-69.64%176.70%598.52%1,337.94%1,818.75%
Deepak Nitrite-34.84%-17.13%156.62%2,712.81%9,563.52%10,252.61%

News Based Sentiment: Samrat Pharmachem vs Deepak Nitrite

Samrat Pharmachem

News based Sentiment: MIXED

October was a month of contrasting fortunes for Samrat Pharmachem, with a significant initial stock surge quickly followed by a decline to a 52-week low. This volatility, combined with mixed financial results, creates a complex investment picture that requires careful consideration.

View Samrat Pharmachem News Sentiment Analysis

Deepak Nitrite

News based Sentiment: MIXED

October's developments for Deepak Nitrite present a mixed picture. While the Q2 FY26 results showed declines in key financial metrics, the stock exhibited both positive and negative technical signals, and its valuation remains at a premium compared to peers. This creates a balanced investment narrative with both opportunities and risks.

View Deepak Nitrite News Sentiment Analysis

Performance & Financial Health Analysis: Samrat Pharmachem vs Deepak Nitrite

MetricSAMRATPHDEEPAKNTR
Market Information
Market Cap i₹1.03B₹253.61B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,850221,309
90 Day Avg. Volume i1,306235,342
Last Close₹307.00₹1,843.80
52 Week Range₹289.00 - ₹425.00₹1,733.90 - ₹3,011.15
% from 52W High-27.76%-38.77%
All-Time High₹1,250.00 (Sep 19, 2022)₹3,169.00 (Jul 29, 2024)
% from All-Time High-75.44%-41.82%
Growth Metrics
Quarterly Revenue Growth-0.06%-0.13%
Quarterly Earnings Growth-0.06%-0.45%
Financial Health
Profit Margin (TTM) i0.02%0.08%
Operating Margin (TTM) i0.00%0.07%
Return on Equity (TTM) i0.10%0.12%
Debt to Equity (MRQ) i13.8123.36
Cash & Liquidity
Book Value per Share (MRQ)₹232.02₹395.08
Cash per Share (MRQ)₹1.70₹66.90
Operating Cash Flow (TTM) i₹1.26M₹7.00B
Levered Free Cash Flow (TTM) i₹71.12M₹6.97B
Dividends
Last 12-Month Dividend Yield i0.29%0.41%
Last 12-Month Dividend i₹1.00₹7.50

Valuation & Enterprise Metrics Analysis: Samrat Pharmachem vs Deepak Nitrite

MetricSAMRATPHDEEPAKNTR
Price Ratios
P/E Ratio (TTM) i20.0041.67
Forward P/E iN/A27.92
PEG Ratio i-0.18-0.93
Price to Sales (TTM) i0.343.16
Price to Book (MRQ) i1.344.69
Market Capitalization
Market Capitalization i₹1.03B₹253.61B
Enterprise Value i₹1.06B₹256.48B
Enterprise Value Metrics
Enterprise to Revenue i0.383.20
Enterprise to EBITDA i13.6126.23
Risk & Other Metrics
Beta i-0.400.14
Book Value per Share (MRQ) i₹232.02₹395.08

Financial Statements Comparison: Samrat Pharmachem vs Deepak Nitrite

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SAMRATPHDEEPAKNTR
Revenue/Sales i₹756.52M₹18.90B
Cost of Goods Sold i₹733.90M₹14.74B
Gross Profit i₹22.62M₹4.16B
Research & Development iN/AN/A
Operating Income (EBIT) i₹-456,000₹1.38B
EBITDA i₹8.16M₹2.14B
Pre-Tax Income i₹2.08M₹1.55B
Income Tax i₹4.37M₹424.90M
Net Income (Profit) i₹-2.29M₹1.12B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SAMRATPHDEEPAKNTR
Cash & Equivalents i₹483,000₹1.79B
Total Current Assets i₹1.03B₹32.97B
Total Current Liabilities i₹495.83M₹9.23B
Long-Term Debt i₹0₹11.14B
Total Shareholders Equity i₹718.00M₹54.25B
Retained Earnings i₹687.11M₹48.27B
Property, Plant & Equipment i₹0₹24.00B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SAMRATPHDEEPAKNTR
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSAMRATPHDEEPAKNTR
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,850221,309
Average Daily Volume (90 Day) i1,306235,342
Shares Outstanding i3.09M136.39M
Float Shares i1.26M67.98M
% Held by Insiders i0.59%0.50%
% Held by Institutions i0.00%0.26%

Dividend Analysis & Yield Comparison: Samrat Pharmachem vs Deepak Nitrite

MetricSAMRATPHDEEPAKNTR
Last 12-Month Dividend i₹1.00₹7.50
Last 12-Month Dividend Yield i0.29%0.41%
3-Year Avg Annual Dividend i₹1.67₹7.50
3-Year Avg Dividend Yield i0.17%0.34%
3-Year Total Dividends i₹5.00₹22.50
Ex-Dividend DateSep 19, 2024Aug 04, 2025